- Home
- SPCE vs FENC Comparison
SPCE vs FENC Comparison
Compare SPCE & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPCE | FENC |
|---|---|---|
| Founded | 2017 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 430.5M | 366.8M |
| IPO Year | 2017 | 2010 |
Fundamental Metrics
Financial Performance| Metric | SPCE | FENC |
|---|---|---|
| Price | $2.47 | $10.12 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 6 |
| Target Price | $3.51 | ★ $17.67 |
| AVG Volume (30 Days) | ★ 4.8M | 109.3K |
| Earning Date | 11-12-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.84 | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | $1,544,000.00 | ★ $44,642,000.00 |
| Revenue This Year | N/A | $62.55 |
| Revenue Next Year | $22,960.98 | $42.10 |
| P/E Ratio | ★ N/A | $172.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.13 | $5.65 |
| 52 Week High | $8.90 | $13.25 |
Technical Indicators
Market Signals| Indicator | SPCE | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 33.70 | 43.15 |
| Support Level | $2.38 | $9.87 |
| Resistance Level | $2.68 | $10.66 |
| Average True Range (ATR) | 0.13 | 0.50 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 17.20 | 27.27 |
Price Performance
Historical ComparisonAbout SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.